MSNews updates are on hold until further notice. Sign-up on our mailing list here to be notified when we are back.
Site implementation: Jaspan Consulting
Graphic design:
The MSNews web site is
There's no real new data here, but it is good to know that dirucotide has passed the data safety monitoring board review for its MAESTRO-01 trial. This drug is being tested on people with SPMS, which is unique.